Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Budesonide Treatment Duration in Eosinophilic Bronchitis
NCT02002715Phase 4Completed
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Mar 2008
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of budesonide in eosinophilic bronchitis (EB), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Started Mar 2008; status: completed.
02
Drugs
budesonide
03
Conditions
eosinophilic bronchitis (EB)
Beyond the preview
Go deeper on NCT02002715.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02002715.